Are you at higher risk for #breastcancer? Join our study to see if personalized Tamoxifen dosing based on breast density changes could lower your risk. Learn more: https://t.co/NB2k21GAgl
On #ClinicalTrialsDay, we celebrate how cancer prevention truly takes a nation💙Thanks to @theNCI, our partner sites, dedicated teams, and above all, cancer fighters for making it all possible!
Talk to a study team member today about a new liver cancer prevention clinical trial for people with #fattyliver disease #NAFLD https://t.co/LgpkKgXKjj
Want to make a difference in breast cancer prevention? Join the RENAISSANCE Study and help us tailor tamoxifen dosing to YOUR needs. Contact us today to see if you are eligible! https://t.co/QugHK06FbJ
The NCPC had a great experience exhibiting at this year’s Lynn Sage Breast Cancer Symposium, connecting with inspiring physicians, researchers, and patient advocates. Thank you to everyone who stopped by to discuss the future of breast cancer prevention with us!
#LSBC24 Seema Khan, MD, of @LurieCancer: Both patients and physicians are increasing focus on the need to personalize radiotherapy decisions for women with DCIS. #breastcancer. The use of molecular scores may add accuracy. @nucancerprevent
All women are at risk for developing a #GynecologicCancer. What do you know about the different gynecologic cancers? Take our quick quiz. https://t.co/vAxCKc6CXe
Does #Atorvastatin protect against #colorectalcancer? Help researchers find answers by joining a clinical trial for patients with ulcerative colitis https://t.co/KvM0ySPrUj
A natural compound called Urolithin A found in pomegranates and berries may improve treatment outcomes in #prostatecancer. Learn more about this exciting new concept here https://t.co/suIGdaOvJZ